0.5125
price up icon3.98%   0.0196
after-market Handel nachbörslich: .50 -0.0125 -2.44%
loading
Schlusskurs vom Vortag:
$0.4929
Offen:
$0.505
24-Stunden-Volumen:
296.70K
Relative Volume:
1.60
Marktkapitalisierung:
$2.17M
Einnahmen:
$502.40K
Nettoeinkommen (Verlust:
$-7.91M
KGV:
-0.0514
EPS:
-9.972
Netto-Cashflow:
$-4.32M
1W Leistung:
+0.83%
1M Leistung:
-47.70%
6M Leistung:
-77.22%
1J Leistung:
-90.60%
1-Tages-Spanne:
Value
$0.494
$0.5229
1-Wochen-Bereich:
Value
$0.4751
$0.54
52-Wochen-Spanne:
Value
$0.45
$6.00

60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile

Name
Firmenname
60 Degrees Pharmaceuticals Inc
Name
Telefon
202-327-5422
Name
Adresse
1025 CONNECTICUT AVENUE NW, WASHINGTON
Name
Mitarbeiter
3
Name
Twitter
Name
Nächster Verdiensttermin
2025-08-15
Name
Neueste SEC-Einreichungen
Name
SXTP's Discussions on Twitter

Vergleichen Sie SXTP mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
SXTP
60 Degrees Pharmaceuticals Inc
0.5125 2.09M 502.40K -7.91M -4.32M -9.972
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.68 122.84B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
801.01 85.37B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
399.40 55.82B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
795.57 50.67B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
170.27 37.54B 447.02M -1.18B -906.14M -6.1812

60 Degrees Pharmaceuticals Inc Aktie (SXTP) Neueste Nachrichten

pulisher
04:34 AM

Published on: 2026-01-09 01:34:54 - ulpravda.ru

04:34 AM
pulisher
04:21 AM

Will 60 Degrees Pharmaceuticals Inc. stock benefit from AI adoptionEarnings Overview Report & High Yield Equity Trading Tips - ulpravda.ru

04:21 AM
pulisher
04:20 AM

Is 60 Degrees Pharmaceuticals Inc. stock a top momentum playJuly 2025 Analyst Calls & Long Hold Capital Preservation Plans - ulpravda.ru

04:20 AM
pulisher
12:47 PM

Published on: 2026-01-08 21:47:54 - ulpravda.ru

12:47 PM
pulisher
12:02 PM

Shorts Report: Will 60 Degrees Pharmaceuticals Inc. stock benefit from AI adoption2025 Earnings Surprises & Real-Time Stock Price Movement Reports - ulpravda.ru

12:02 PM
pulisher
11:30 AM

Will 60 Degrees Pharmaceuticals Inc. Equity Warrant stock deliver long term returnsJuly 2025 Short Interest & Safe Capital Growth Tips - ulpravda.ru

11:30 AM
pulisher
11:08 AM

Published on: 2026-01-08 20:08:34 - ulpravda.ru

11:08 AM
pulisher
10:55 AM

Will 60 Degrees Pharmaceuticals Inc. stock deliver consistent dividendsWeekly Trade Report & Long Hold Capital Preservation Tips - ulpravda.ru

10:55 AM
pulisher
10:49 AM

Why 60 Degrees Pharmaceuticals Inc. Equity Warrant stock appeals to analystsMarket Performance Recap & Fast Entry and Exit Trade Plans - ulpravda.ru

10:49 AM
pulisher
09:46 AM

Processa Pharmaceuticals and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Progress Index

09:46 AM
pulisher
09:41 AM

60 Degrees Pharma outlines growth strategy in investor webinar - TipRanks

09:41 AM
pulisher
09:22 AM

Can 60 Degrees Pharmaceuticals Inc. Equity Warrant stock maintain growth trajectoryDividend Hike & Verified Entry Point Detection - ulpravda.ru

09:22 AM
pulisher
09:03 AM

60 Degrees Pharmaceuticals, Inc. Updates on Clinical Development and Regulatory Strategy - TradingView — Track All Markets

09:03 AM
pulisher
Jan 06, 2026

Why 60 Degrees Pharmaceuticals Inc. Equity Warrant stock appeals to dividend seekers2026 world cup usa national team final star players transition play group prediction tactical review - ulpravda.ru

Jan 06, 2026
pulisher
Jan 05, 2026

Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Jackson Sun

Jan 05, 2026
pulisher
Jan 02, 2026

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Jan 02, 2026
pulisher
Dec 30, 2025

60 Degrees Pharmaceuticals Inc. (NASDAQ:SXTP) Sees Large Growth in Short Interest - Defense World

Dec 30, 2025
pulisher
Dec 29, 2025

60 Degrees Pharmaceuticals, Inc. Confirms Continuation of B-FREE Study to Assess ARAKODA® for Chronic Babesiosis Treatment - Quiver Quantitative

Dec 29, 2025
pulisher
Dec 29, 2025

60 Degrees Pharmaceuticals Announces Detection of Babesia - GlobeNewswire

Dec 29, 2025
pulisher
Dec 29, 2025

60 Degrees Pharmaceuticals Announces Detection of Babesia Infection in 24 Percent of Patients Presenting with Chronic Fatigue in Peer-Reviewed, Sponsored Study at NC State - Sahm

Dec 29, 2025
pulisher
Dec 29, 2025

Tick-borne parasite found in 1 in 4 people with chronic fatigue in new study - Stock Titan

Dec 29, 2025
pulisher
Dec 28, 2025

60 Degrees Pharmaceuticals and NDT Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Coloradoan

Dec 28, 2025

Finanzdaten der 60 Degrees Pharmaceuticals Inc-Aktie (SXTP)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$33.63
price down icon 0.80%
$107.39
price up icon 4.56%
$105.92
price down icon 4.21%
$98.85
price down icon 1.23%
biotechnology ONC
$320.37
price down icon 4.04%
$170.27
price down icon 3.26%
Kapitalisierung:     |  Volumen (24h):